down arrow

SMS Pharma.

45
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE812G01025
  • NSEID: SMSPHARMA
  • BSEID: 532815
INR
204.10
5.9 (2.98%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 65.74 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
752.00
554.00
555.00
611.00
453.00
511.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
43.00
32.00
35.00
48.00
41.00
46.00
Net Sales
709.00
522.00
519.00
563.00
411.00
464.00
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
36.00
-112.00
26.00
-13.00
-14.00
Raw Materials Consumed
425.00
299.00
387.00
313.00
259.00
307.00
Power & Fuel Cost
47.00
35.00
32.00
23.00
18.00
21.00
Employee Cost
64.00
53.00
51.00
41.00
39.00
35.00
Operating Expenses
26.00
17.00
22.00
16.00
14.00
13.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
4.00
3.00
3.00
5.00
3.00
2.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
2.00
2.00
2.00
2.00
2.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
592.00
467.00
405.00
442.00
332.00
374.00
Operating Profit (PBDIT) excl Other Income
116.00
54.00
114.00
121.00
79.00
90.00
Other Income
4.00
4.00
5.00
3.00
5.00
3.00
Operating Profit (PBDIT)
121.00
59.00
119.00
124.00
85.00
93.00
Interest
23.00
21.00
18.00
11.00
12.00
11.00
Profit before Depriciation and Tax
97.00
37.00
100.00
113.00
72.00
81.00
Depreciation
31.00
32.00
32.00
22.00
22.00
19.00
Profit Before Taxation & Exceptional Items
66.00
5.00
68.00
91.00
50.00
62.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
66.00
5.00
68.00
91.00
50.00
62.00
Provision for Tax
16.00
1.00
0.00
30.00
18.00
20.00
Profit After Tax
49.00
3.00
67.00
60.00
32.00
41.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
287.00
297.00
247.00
195.00
179.00
151.00
Profit Available for appropriations
337.00
290.00
309.00
257.00
210.00
191.00
Appropriations
337.00
290.00
309.00
257.00
210.00
191.00
Equity Dividend (%)
40.00%
30.00%
30.00%
30.00%
25.00%
25.00%
Earnings Per Share
5.89
-0.83
7.35
7.39
3.73
4.73
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 35.86% vs 0.42% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 114.08% vs -52.35% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 7.04% vs 16.09% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 1,166.70% vs -94.28% in Mar 2023

Compare Profit and Loss Results of SMS Pharma.
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
752.00
10,334.00
-9,582.00
-92.72%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
43.00
0.00
43.00
0%
Net Sales
709.00
10,334.00
-9,625.00
-93.14%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-94.00
93.00
98.94%
Raw Materials Consumed
425.00
3,263.00
-2,838.00
-86.98%
Power & Fuel Cost
47.00
129.00
-82.00
-63.57%
Employee Cost
64.00
2,274.00
-2,210.00
-97.19%
Operating Expenses
26.00
210.00
-184.00
-87.62%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
928.00
-924.00
-99.57%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
134.00
-132.00
-98.51%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
592.00
7,798.00
-7,206.00
-92.41%
Operating Profit (PBDIT) excl Other Income
116.00
2,536.00
-2,420.00
-95.43%
Other Income
4.00
280.00
-276.00
-98.57%
Operating Profit (PBDIT)
121.00
2,817.00
-2,696.00
-95.70%
Interest
23.00
35.00
-12.00
-34.29%
Profit before Depriciation and Tax
97.00
2,782.00
-2,685.00
-96.51%
Depreciation
31.00
398.00
-367.00
-92.21%
Profit Before Taxation & Exceptional Items
66.00
2,384.00
-2,318.00
-97.23%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
66.00
2,399.00
-2,333.00
-97.25%
Provision for Tax
16.00
457.00
-441.00
-96.50%
Profit After Tax
49.00
1,926.00
-1,877.00
-97.46%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
287.00
8,012.00
-7,725.00
-96.42%
Profit Available for appropriations
337.00
9,925.00
-9,588.00
-96.60%
Appropriations
337.00
9,925.00
-9,588.00
-96.60%
Equity Dividend (%)
40%
0%
40.00
Earnings Per Share
5.89
47.75
-41.86
-87.66%
Profit And Loss - Net Sales
Net Sales 709.26 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 35.86% vs 0.42% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 116.62 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 114.08% vs -52.35% in Mar 2023

Profit And Loss - Interest
Interest 23.46 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 7.04% vs 16.09% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 49.20 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 1,166.70% vs -94.28% in Mar 2023